Mimedx Group EBIT

The latest EBIT for MDXG is $8.3M as of June 2026. That compares with $41M in the prior-year period — down 79.5% year over year. That is below the Industrials sector average of $38B. Investors often review this figure alongside Mimedx Group's historical trend and sector peers before judging valuation or financial health.

Over the past year, MDXG's EBIT moved from $41M to $8.3M — a 79.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mimedx Group's operating scale or balance-sheet position.

Against Industrials companies, MDXG currently prints $8.3M for EBIT, while the sector average sits near $38B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Mimedx Group's growth, margins, and balance sheet.

A EBIT figure of $8.3M for MDXG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Industrials average is about $38B. Explore the charts below for those layers of context.

After noting MDXG's EBIT ($8.3M), review year-over-year change from $41M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.